| Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer International Adjuvant Lung Cancer Trial Collaborative Group New England Journal of Medicine 350 (4), 351-360, 2004 | 2996 | 2004 |
| Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer E Van Cutsem, M Peeters, S Siena, Y Humblet, A Hendlisz, B Neyns, ... Journal of clinical oncology 25 (13), 1658-1664, 2007 | 2412 | 2007 |
| Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer S Chan, K Friedrichs, D Noel, T Pintér, S Van Belle, D Vorobiof, R Duarte, ... Journal of Clinical Oncology 17 (8), 2341-2341, 1999 | 823 | 1999 |
| Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials A Lipton, K Fizazi, AT Stopeck, DH Henry, JE Brown, DA Yardley, ... European journal of cancer 48 (16), 3082-3092, 2012 | 633 | 2012 |
| Tirapazamine plus cisplatin versus cisplatin in advanced non–small-cell lung cancer: A report of the International CATAPULT I Study Group J Von Pawel, R von Roemeling, U Gatzemeier, M Boyer, LO Elisson, ... Journal of Clinical Oncology 18 (6), 1351-1359, 2000 | 369 | 2000 |
| Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial BJ Monk, A Poveda, I Vergote, F Raspagliesi, K Fujiwara, DS Bae, ... The lancet oncology 15 (8), 799-808, 2014 | 347 | 2014 |
| Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers GE Richardson, MA Tucker, DJ Venzon, RI Linnoila, R Phelps, JC Phares, ... Annals of Internal Medicine 119 (5), 383-390, 1993 | 307 | 1993 |
| Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer J von Pawel, U Gatzemeier, JL Pujol, L Moreau, S Bildat, M Ranson, ... Journal of clinical oncology 19 (6), 1743-1749, 2001 | 268 | 2001 |
| Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer BY Karlan, AM Oza, GE Richardson, DM Provencher, VL Hansen, M Buck, ... Journal of clinical oncology 30 (4), 362-371, 2012 | 233 | 2012 |
| Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label … E Pujade-Lauraine, K Fujiwara, JA Ledermann, AM Oza, R Kristeleit, ... The lancet oncology 22 (7), 1034-1046, 2021 | 207 | 2021 |
| Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics A Lipton, K Fizazi, AT Stopeck, DH Henry, MR Smith, N Shore, M Martin, ... European Journal of Cancer 53, 75-83, 2016 | 127 | 2016 |
| A prospective study of patients with lung cancer and hyponatremia of malignancy BE Johnson, JP Chute, J Rushin, J Williams, PT Le, D Venzon, ... American journal of respiratory and critical care medicine 156 (5), 1669-1678, 1997 | 110 | 1997 |
| Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): long-term survival, impact of ascites, and progression-free … BJ Monk, A Poveda, I Vergote, F Raspagliesi, K Fujiwara, DS Bae, ... Gynecologic oncology 143 (1), 27-34, 2016 | 104 | 2016 |
| Phase I, open-label, dose-escalation/dose-expansion study of lifirafenib (BGB-283), an RAF family kinase inhibitor, in patients with solid tumors J Desai, H Gan, C Barrow, M Jameson, V Atkinson, A Haydon, M Millward, ... Journal of Clinical Oncology 38 (19), 2140, 2020 | 82 | 2020 |
| Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant or refractory epithelial ovarian cancer … E Pujade-Lauraine, K Fujiwara, JA Ledermann, AM Oza, RS Kristeleit, ... Gynecologic Oncology 154, 21-22, 2019 | 68 | 2019 |
| Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. BE Johnson, RI Linnoila, JP Williams, DJ Venzon, P Okunieff, ... Journal of clinical oncology 13 (1), 101-111, 1995 | 67 | 1995 |
| Impact of primary tumor site on bevacizumab efficacy in metastatic colorectal cancer H Wong, B Lee, K Field, A Lomax, M Tacey, J Shapiro, J McKendrick, ... Clinical colorectal cancer 15 (2), e9-e15, 2016 | 63 | 2016 |
| Reported management of lung cancer in Victoria in 1993: comparison with best practice GE Richardson, VJ Thursfield, GG Giles, ... Medical Journal of Australia 172 (7), 321-324, 2000 | 61 | 2000 |
| Lung cancer in Victoria: are we making progress? PLR Mitchell, VJ Thursfield, DL Ball, GE Richardson, LB Irving, ... Medical Journal of Australia 199 (10), 674-679, 2013 | 55 | 2013 |
| The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer T Seshadri, HM Prince, DR Bell, PB Coughlin, PPB James, ... Medical journal of Australia 182 (9), 453-457, 2005 | 54 | 2005 |
Jeremy Shapiromonash universityVerified email at monash.edu
